🔥Telegram İfşa

With Delve Detect, one test can detect nearly any type of infection, eliminating the need for lengthy cycles of multiple tests. #genomics #mNGS #infectiousdisease

When a patient has a serious central nervous system infection, quickly identifying what’s wrong is critical. Our flagship mNGS testing service delivers comprehensive pathogen identification in just 48 hours, letting you quickly rule in or rule out an infection. Learn more about

Roughly half of patients with encephalitis never know what caused it. We’re proud to be part of the community working to improve diagnosis and care for people with encephalitis. In honor of #WorldEncephalitisDay, take a moment to learn more about the condition from Encephalitis

Genomic sequencing has transformed cancer treatment, but #dyk it’s poised to do the same for infectious diseases? Using metagenomic sequencing, Delve Detect can screen for nearly all known pathogens with a single sample. Find out more about this game-changing technology

#ICYMI Remarkable Washington Post story from Michael Lewis detailing the experience of a young girl with a rare neurologic infection diagnosed by Delve founders Drs. Joe DeRisi and Michael Wilson using #mNGS. A must-read #longread this week. wapo.st/4hKvJ2V

Our team is excited to be headed to San Diego for the American Academy of Neurology Annual meeting. Whether you're joining in person or online, don't miss the data we're presenting on Monday and stop by our booth to learn more about how metagenomics is improving diagnosis for

We’re at the American Academy of Neurology Annual Meeting today sharing data on our proprietary platform, Delve Decide, which powers a 20% increased diagnostic yield over conventional diagnostics for meningitis and encephalitis -and delivers results in 48 hours. Read more in our

Delve Bio is proud to be at #PASCV25 with groundbreaking data showing our bioinformatics platform, Delve Decide, demonstrated the capability to deliver viral subtyping directly from original sequence data. Learn more in our press release. #genomics bit.ly/4jGbK7n.

The Delve Bio team and Delve co-founder Charles Chiu are excited to be headed to the PASCV Annual Meeting to talk about how #metagenomics is changing the game in pathogen detection and diagnostics. Be sure to stop by our booth to hear more. #PASCV25 #Microbiology #Virology

Heading to #ASMicrobe? Get a jump-start on the conference at our session on how mNGS is transforming infectious disease diagnostics on June 19. Find out more here: bit.ly/delveworkshop #ASMicrobe

Heading to #ASMicrobe? Get a jump-start on the conference at our session on how mNGS is transforming infectious disease diagnostics on June 19. Find out more here: bit.ly/delveworkshop #ASMicrobe

We’re bringing infectious disease diagnostics into the genomic era. Come meet our team and learn more this week at booth #1440 at #ASMicrobe. Learn more about our work at delve.bio

Working on your #ASMicrobe itinerary? Don’t miss this poster on the use of #mNGS to diagnose culture-negative infection. bit.ly/asmmoraxella

New data from #ASMicrobe shows the advantages of Delve Detect over traditional testing in #meningitis and #encephalitis — 24% more diagnoses, including co-infections & novel pathogens. Our #mNGS offers broad, unbiased testing in just 48 hrs with expert review. #infectiousdisease

Comprehensive pathogen detection needs both DNA & RNA analysis. Delve Detect delivers both—ensuring broad, unbiased pathogen detection. Explore the tech: delve.bio/product/

Finding a diagnosis as quickly as possible is critical in cases of meningitis and encephalitis. That’s why we’ve focused intently on delivering answers – 22% more of them – in just 48 hours. Learn more about what we’ve been up to in GenomeWeb. #Diagnostics #mNGS

Speed is critical in cases of meningitis and encephalitis. That’s why we’ve focused intently on delivering answers – 22% more of them – in just 48 hours. Learn more about what we’ve been up to in GenomeWeb. #Diagnostics #mNGS #InfectiousDisease bit.ly/4eulM9U

PCR panels target what you already suspect. Metagenomic sequencing finds what you didn’t. Learn more about the power of #mNGS delve.bio/product/

No more guessing. Delve's mNGS platform detects 68,000+ pathogens - both RNA and DNA! - in one test in just 48 hours. #InfectiousDisease #mNGS #PrecisionMedicine